Pharmacokinetic/pharmacodynamic study of sequence specificity of the PARP inhibitor, olaparib and carboplatin in recurrent women's cancers

The requested reference [dad7e44da6af212dea959801e6b64b5cc6980c2f] no longer exists in our database. It has been replaced by the current reference: [4262e9377fe36e531703a7bc975649e1c1359b9b]

Authors
Category Primary study
JournalCancer Research
Year 2015
This article has no abstract
Epistemonikos ID: 4fb46278b337c5816d7e87d86eb5872114cbbd5e
First added on: Feb 07, 2025